Smith et al. found no concordance between p16INK4a expression and HPV detection in 20 % of head and neck cancers [31], possibly due to transcriptionally inactive infection or an alternate pathway of p16INK4a activation [34]. Here, CDKN2A is linked to head and neck cancer.